Illustration: Tiffany Herring/Axios
Colossal Biosciences, the Austin-based "de-extinction" company that's bringing back the woolly mammoth and Tasmanian tiger, closed a $150 million Series B to fund a new effort to revive the dodo.
Why it matters: The climate movement, at its most fundamental level, is about protecting the Earth. Colossal Biosciences hopes to repair some of the damage already done.
